Polycystin-2 associates with tropomyosin-1, an actin microfilament component

Journal of Molecular Biology

Volumn 325, Issue 5, 2003, Pages 949-962

  Li, Qiang ^a   Dai, Yue ^a   Guo, Lei ^a   Liu, Yan ^a   Hao, Chunhai ^a   Wu, Guanqing ^b   Basora, Nuria ^c   Michalak, Marek ^a   Chen, Xing Zhen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

ADPKD; Co immunoprecipitation; PKD2; TM 1; Yeast two hybrid screen

Indexed keywords

ACTIN; ISOPROTEIN; POLYCYSTIN; TROPOMYOSIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; HEART; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; KIDNEY; KIDNEY CELL; MICROTITER PLATE ASSAY; MOUSE; MUSCLE CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO HYBRID SYSTEM; XENOPUS;

EID: 0037474534     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)01333-5     Document Type: Article

References (58)

1. Gabow P.A. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329:1993;332-342.
2. Boulter C., Mulroy S., Webb S., Fleming S., Brindle K., Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl Acad. Sci. USA. 98:2001;12174-12179.
3. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell. 81:1995;289-298.
4. Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K., San Millan J.L., et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genet. 10:1995;151-160.
5. Geng L., Segal Y., Pavlova A., Barros E.J., Lohning C., Lu W., et al. Distribution and developmentally regulated expression of murine polycystin. Am. J. Physiol. 272:1997;F451-F459.
6. Lu W., Peissel B., Babakhanlou H., Pavlova A., Geng L., Fan X., et al. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nature Genet. 17:1997;179-181.
7. Kim K., Drummond I., Ibraghimov-Beskrovnaya O., Klinger K., Arnaout M.A. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl Acad. Sci. USA. 97:2000;1731-1736.
8. Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B., Saris J.J., et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 272:1996;1339-1342.
9. Nomura H., Turco A.E., Pei Y., Kalaydjieva L., Schiavello T., Weremowicz S., et al. Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J. Biol. Chem. 273:1998;25967-25973.
10. Perez-Reyes E., Cribbs L.L., Daud A., Lacerda A.E., Barclay J., Williamson M.P., et al. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature. 391:1998;896-900.
11. Kiselyov K., Xu X., Mozhayeva G., Kuo T., Pessah I., Mignery G., et al. Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature. 396:1998;478-482.
12. 2+-permeable nonselective cation channel. Proc. Natl Acad. Sci. USA. 98:2001;1182-1187.
13. Liu Y., Li Q., Tan M., Zhang Y.-Y., Karpinski E., Zhou J., et al. Modulation of the human polycystin-L channel by voltage and divalent cations. FEBS Letters. 525:2002;71-76.
14. Li Q., Liu Y., Zhao W., Chen X.-Z. The calcium binding EF-hand in polycystin-L is not a domain for channel activation and ensuing inactivation. FEBS Letters. 516:2002;270-278.
15. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., et al. Polycystin-2 is an intracellular calcium release channel. Nature Cell Biol. 4:2002;191-197.
16. Chen X.Z., Vassilev P.M., Basora N., Peng J.B., Nomura H., Segal Y., et al. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature. 401:1999;383-386.
17. Vassilev P.M., Guo L., Chen X.Z., Segal Y., Peng J.B., Basora N., et al. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 282:2001;341-350.
18. Ong A.C., Ward C.J., Butler R.J., Biddolph S., Bowker C., Torra R., et al. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am. J. Pathol. 154:1999;1721-1729.
19. Wu G., D'Agati V., Cai Y., Markowitz G., Park J.H., Reynolds D.M., et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell. 93:1998;177-188.
20. Wu G., Markowitz G.S., Li L., D'Agati V.D., Factor S.M., Geng L., et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nature Genet. 24:2000;75-78.
21. Scheffers M.S., Le H., van Der B.P., Leonhard W., Prins F., Spruit L., et al. Distinct subcellular expression of endogenous polycystin-2 in the plasma membrane and Golgi apparatus of MDCK cells. Hum. Mol. Genet. 11:2002;59-67.
22. Cai Y., Maeda Y., Cedzich A., Torres V.E., Wu G., Hayashi T., et al. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 274:1999;28557-28565.
23. Foggensteiner L., Bevan A.P., Thomas R., Coleman N., Boulter C., Bradley J., et al. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J. Am. Soc. Nephrol. 11:2000;814-827.
24. Chen X.Z., Segal Y., Basora N., Guo L., Peng J.B., Babakhanlou H., et al. Transport function of the naturally occurring pathogenic polycystin-2 mutant, R742X. Biochem. Biophys. Res. Commun. 282:2001;1251-1256.
25. Qian F., Germino F.J., Cai Y., Zhang X., Somlo S., Germino G.G. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nature Genet. 16:1997;179-183.
26. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature. 408:2000;990-994.
27. Tsiokas L., Kim E., Arnould T., Sukhatme V.P., Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl Acad. Sci. USA. 94:1997;6965-6970.
28. Newby L.J., Streets A.J., Zhao Y., Harris P.C., Ward C.J., Ong A.C. Identification, characterisation and localisation of a novel kidney polycystin-1/polycystin-2 complex. J. Biol. Chem. 277:2002;20763-20773.
29. Tsiokas L., Arnould T., Zhu C., Kim E., Walz G., Sukhatme V.P. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc. Natl Acad. Sci. USA. 96:1999;3934-3939.
30. Lehtonen S., Ora A., Olkkonen V.M., Geng L., Zerial M., Somlo S., et al. In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2. J. Biol. Chem. 275:2000;32888-32893.
31. Gallagher A.R., Cedzich A., Gretz N., Somlo S., Witzgall R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc. Natl Acad. Sci. USA. 97:2000;4017-4022.
32. Gunning P., Hardeman E., Jeffrey P., Weinberger R. Creating intracellular structural domains: spatial segregation of actin and tropomyosin isoforms in neurons. Bioessays. 20:1998;892-900.
33. Gunning P., Weinberger R., Jeffrey P. Actin and tropomyosin isoforms in morphogenesis. Anat. Embryol. (Berl). 195:1997;311-315.
34. Lehman W., Hatch V., Korman V., Rosol M., Thomas L., Maytum R., et al. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J. Mol. Biol. 302:2000;593-606.
35. Temm-Grove C.J., Jockusch B.M., Weinberger R.P., Schevzov G., Helfman D.M. Distinct localizations of tropomyosin isoforms in LLC-PK1 epithelial cells suggests specialized function at cell-cell adhesions. Cell Motil. Cytoskeleton. 40:1998;393-407.
36. Prasad G.L., Fuldner R.A., Cooper H.L. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl Acad. Sci. USA. 90:1993;7039-7043.
37. Mahadev K., Raval G., Bharadwaj S., Willingham M., Lange E., Vonderhaar B., et al. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Expt. Cell Res. 279:2002;40-51.
38. Pittenger M.F., Kazzaz J.A., Helfman D.M. Functional properties of non-muscle tropomyosin isoforms. Curr. Opin. Cell Biol. 6:1994;96-104.
39. Pittenger M.F., Kistler A., Helfman D.M. Alternatively spliced exons of the beta tropomyosin gene exhibit different affinities for F-actin and effects with nonmuscle caldesmon. J. Cell Sci. 108:1995;3253-3265.
40. Stamm S., Casper D., Lees-Miller J.P., Helfman D.M. Brain-specific tropomyosins TMBr-1 and TMBr-3 have distinct patterns of expression during development and in adult brain. Proc. Natl Acad. Sci. USA. 90:1993;9857-9861.
41. Matsumura F., Lin J.J., Yamashiro-Matsumura S., Thomas G.P., Topp W.C. Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J. Biol. Chem. 258:1983;13954-13964.
42. Ishino T., Kobayashi R., Wakui H., Fukushima Y., Nakamoto Y., Miura A.B. Biochemical characterization of contractile proteins of rat cultured mesangial cells. Kidney Int. 39:1991;1118-1124.
43. Prasad G.L., Meissner S., Sheer D.G., Cooper H.L. A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1. Biochem. Biophys. Res. Commun. 177:1991;1068-1075.
44. Helfman D.M., Cheley S., Kuismanen E., Finn L.A., Yamawaki-Kataoka Y. Nonmuscle and muscle tropomyosin isoforms are expressed from a single gene by alternative RNA splicing and polyadenylation. Mol. Cell Biol. 6:1986;3582-3595.
45. MacLeod A.R., Houlker C., Reinach F.C., Smillie L.B., Talbot K., Modi G., et al. A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism. Proc. Natl Acad. Sci. USA. 82:1985;7835-7839.
46. Solaro R.J., Rarick H.M. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ. Res. 83:1998;471-480.
47. Matagne A., Joris B., Frere J.M. Anomalous behaviour of a protein during SDS/PAGE corrected by chemical modification of carboxylic groups. Biochem. J. 280:1991;553-556.
48. Nakamura K., Zuppini A., Arnaudeau S., Lynch J., Ahsan I., Krause R., et al. Functional specialization of calreticulin domains. J. Cell Biol. 154:2001;961-972.
49. Lin J.J., Warren K.S., Wamboldt D.D., Wang T., Lin J.L. Tropomyosin isoforms in nonmuscle cells. Int. Rev. Cytol. 170:1997;1-38.
50. Lin J.J., Hegmann T.E., Lin J.L. Differential localization of tropomyosin isoforms in cultured nonmuscle cells. J. Cell Biol. 107:1988;563-572.
51. Markowitz G.S., Cai Y., Li L., Wu G., Ward L.C., Somlo S., et al. Polycystin-2 expression is developmentally regulated. Am. J. Physiol. 277:1999;F17-F25.
52. Xu G.M., Sikaneta T., Sullivan B.M., Zhang Q., Andreucci M., Stehle T., et al. Polycystin-1 interacts with intermediate filaments. J. Biol. Chem. 276:2001;46544-46552.
53. Herrmann H., Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12:2000;79-90.
54. Shah V., Braverman R., Prasad G.L. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins. Somat. Cell Mol. Genet. 24:1998;273-280.
55. Kleymenova E., Ibraghimov-Beskrovnaya O., Kugoh H., Everitt J., Xu H., Kiguchi K., et al. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol. Cell. 7:2001;823-832.
56. Grantham J.J. Polycystic kidney disease: neoplasia in disguise. Am. J. Kidney Dis. 15:1990;110-116.
57. Vince J.W., Reithmeier R.A. Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1-/. J. Biol. Chem. 273:1998;28430-28437.
58. Lorenz C., Pusch M., Jentsch T.J. Heteromultimeric CLC chloride channels with novel properties. Proc. Natl Acad. Sci. USA. 93:1996;13362-13366.